Показано 0 из 0
Дата |
---|
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
49.50
|
47.00
|
49.50
|
49.00
|
|
|
23 300.00
|
12.00
|
|
|
48.50
|
48.00
|
50.20
|
48.00
|
|
|
42 670.00
|
20.00
|
|
|
48.50
|
48.50
|
49.60
|
48.50
|
|
|
2 110.00
|
8.00
|
|
|
49.00
|
47.00
|
49.40
|
48.50
|
|
|
102 670.00
|
49.00
|
|
|
48.00
|
48.00
|
50.20
|
50.20
|
|
|
21 450.00
|
13.00
|
|
|
47.80
|
47.80
|
49.90
|
49.90
|
|
|
28 240.00
|
21.00
|
|
|
48.70
|
46.40
|
48.70
|
48.70
|
|
|
36 180.00
|
17.00
|
|
|
49.30
|
48.20
|
49.40
|
48.70
|
|
|
117 290.00
|
36.00
|
|
|
49.70
|
49.10
|
51.00
|
50.80
|
|
|
59 850.00
|
25.00
|
|
|
50.00
|
49.70
|
51.20
|
51.00
|
|
|
45 480.00
|
14.00
|
Poltreg SA is a biotechnology company whose activity focuses on the development of a polypharmacological platform that is the basis for the development of innovative therapies using T-regulatory cells (TREGS), as well as work on combination therapies based on TREGS treatment and e.g. antibodies.